[VRTX] YoY Annual Result on 31-Dec-2015 [#FY]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
16-Feb-2016
Financial Year
2015
Quarter
31-Dec-2015 [#FY]
Profit Trend
YoY- 24.43%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Annual Result
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Revenue 3,047,597 2,488,652 1,702,177 1,032,336 580,415 1,211,975 1,527,042 12.20%
PBT 600,241 -15,689 -67,366 -559,581 -734,875 -976,117 -12,381 -
Tax -1,486,862 -107,324 16,665 30,381 6,958 -288,567 38,754 -
NP 2,096,896 263,484 -112,052 -558,115 -738,555 -445,028 -107,032 -
Tax Rate 247.71% - - - - - - -
Total Cost 950,701 2,225,168 1,814,229 1,590,451 1,318,970 1,657,003 1,634,074 -8.62%
Ratio Analysis
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
NP Margin 68.80 10.59 -6.58 -54.06 -127.25 -36.72 -7.01 -
Per Share
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
EPS 8.25 1.06 -0.46 -2.32 -3.14 -1.98 -0.50 -
EPS Diluted 8.09 1.04 -0.46 -2.31 -3.14 -1.98 -0.50 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.